SCHEMBL3781135

SCHEMBL3781135

CCON(CC)S(=O)(=O)C(C)(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770074 0.82 CYP4F2 (0.34)
SCHEMBL3777121 0.66 ALDH1A1 (0.36)
SCHEMBL3777829 0.64 CA12 (0.35)
SCHEMBL1619351 0.64 TSHR (0.38)
SCHEMBL9645782 0.63
SCHEMBL19312138 0.62 TSHR (0.36)
SCHEMBL3779380 0.61 ALDH1A1 (0.32)
SCHEMBL10714767 0.60 ALDH1A1 (0.44)
Acetic Acid SCHEMBL27501735 0.59 ALDH1A1 (0.39)
SCHEMBL1620945 0.59 NOS2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546563-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-01 US disclosed
EP-2217565-B1 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INT (DE) 2013-05-22 EP disclosed
US-20100331304-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-12-30 US disclosed